INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTHRAX

File: 123096_sep96_decls12_0007.txt
Page: 0007
Total Pages: 32

Subject: INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTHRAX             

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: CAUTIONARY NOTE                                                                                 

Document Number:          2

Folder Seq  #:         14








                             (a) Cluster of S14 with respiratory                       (febrile
             mwimtory             , sudden cnset/outbreak in the @ area of operations at
             the sme time, rapid             icn to strider and respiratcmy @ficienw,
                               on        X-ray with and/or wi                    effusicn
             without             infiltrates)

                             (b) @lained animl i I bless and death

                             (c) Knmm or            anthrax respiratory            risk or cases
             in area of operation

                             (d)       ained         c @iratory deaths, acute resPiratOrY
             failure or insuffir-iericy

                   b. BotulimEn         - Sign and            - blurred vision,                arld
             difficulty in           and really

             2.3 Post             Txwtment for Anthrax             St4

                   a. All St4 wUl be i-@ied a bl          pack of ten C#mfla=in tablets
             (500 mg) w:Lth           cns to take one tablet every 12 hours. @ decision
             to begin         the antibiotic will be @ by the tactical                    based
             on ccnf@tion of                or @ probability of               - @ tactical
                        will be adv@ by his Irytelligmm OfficL-X, sltrgemf and Chemical
             offioer. other hacators of a Bw attack are                  r    the few BFA
             detectcxs deployed               at selected sites and the NBC
             System-

                   b. If an attack w:Lth anthrax has been ccnf           the SM @ ccDPl@
             the vaccimton series. in add:Lticn, ciproflcxacin antibiauc treatment will
                       for at least 30 days. If suspicious cl@Cal                  O=W, SK
             will be treated with oral Ciprofloxacin (1000 mg l@ dose, then 750 mg
             twice daily) or                         im (200 mg loading dose, then 100 mg
            twioe daily).                 @flcxacin is not available at the Preserrt
             tire.)

             2.4 Cmt            Stock of          Vaocim for Trea          Of           SM

                   a.               anthrax vaocim stocks w3ll be dedicated for the
             treatment of anthrax exposed sK. @ stock will be positioned in the AcR
             @cal treatment facilities                a          to          priorities and
                        on plan.                    ties of this vaocim
                   d be periodically evaluated by

                   b.           tic          patients       d receive aggressive ant3bl@c
                      (para 7b) and be prov@               ve care- Vaccim           d be
                           to those who are               to antibiotic therapy.




                                                       2-2

Document 32 f:/Week-36/BX003201/CAUTIONARY NOTE/interim medical doctrine bw defense against anth:12179609280113
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = CAUTIONARY NOTE
Folder Seq # = 14
Subject = INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTH
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996